Literature DB >> 30094476

The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.

Luis R Espinoza1.   

Abstract

PURPOSE OF REVIEW: Psoriatic arthritis is a distinct disorder, separate from rheumatoid arthritis, and first recognized in a thirteenth century Saxon skeleton. It was, however, the monumental work of Verna Wright in the 1950s that led to the acceptance by the American Rheumatism Association (now American College of Rheumatology) in 1964 as a distinct entity. Wright's work provided the framework for a better understanding of the pathogenic mechanisms operating on this condition, and eventually led to the development of targeted therapy that has proven to be more effective and safe than conventional therapy. RECENT
FINDINGS: Pathogenesis of psoriatic arthritis has been better delineated in recent years, as well as the use of biological therapy. Recent findings are discussed in detail. Historical aspects of psoriatic arthritis, recent developments in pathogenesis, and therapy are discussed, and the contributions of Verna Wright to our understanding of the disorder are presented.

Entities:  

Keywords:  Biologic therapy; Cytokines; Growth factors; Microbiota; Psoriasis; Psoriatic arthritis; Spondyloarthritis

Mesh:

Substances:

Year:  2018        PMID: 30094476     DOI: 10.1007/s11926-018-0771-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  67 in total

1.  Psoriasis and arthritis.

Authors:  V WRIGHT
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

2.  Rheumatism and arthritis; review of American and English literature of recent years.

Authors:  P S HENCH; W BAUER
Journal:  Ann Intern Med       Date:  1948-01       Impact factor: 25.391

3.  Psoriasis arthropathica.

Authors:  X VILANOVA; J PINOL
Journal:  Rheumatism       Date:  1951-01

4.  Psoriatic Arthritis.

Authors:  Christopher T Ritchlin; Robert A Colbert; Dafna D Gladman
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

5.  Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses.

Authors:  L R Espinoza; J L Aguilar; C G Espinoza; M L Cuéllar; E Scopelitis; L H Silveira
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

6.  Vascular changes in psoriatic synovium. A light and electron microscopic study.

Authors:  L R Espinoza; F B Vasey; C G Espinoza; T S Bocanegra; B F Germain
Journal:  Arthritis Rheum       Date:  1982-06

Review 7.  Insights into the pathogenesis of psoriasis and psoriatic arthritis.

Authors:  L R Espinoza; R van Solingen; M L Cuellar; J Angulo
Journal:  Am J Med Sci       Date:  1998-10       Impact factor: 2.378

8.  Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines.

Authors:  L R Espinoza; C G Espinoza; M L Cuéllar; E Scopelitis; L H Silveira; G R Grotendorst
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

9.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

10.  Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.

Authors:  Atul Deodhar; Alice B Gottlieb; Wolf-Henning Boehncke; Bin Dong; Yuhua Wang; Yanli Zhuang; William Barchuk; Xie L Xu; Elizabeth C Hsia
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

View more
  2 in total

Review 1.  Trauma-induced concomitant psoriatic arthritis and complex regional pain syndrome.

Authors:  Jose A Leon de la Rocha; Nirupa J Patel; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2019-05-24       Impact factor: 2.980

2.  Expanding the spectrum of spondyloarthritis (SpA): post-streptococcal reactive arthritis (PSRA)-related psoriatic spondyloarthritis (PSpA).

Authors:  Karen I Vega-Villanueva; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2019-08-06       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.